Chemring Group PLC Business Analysis and Insights

Author

Reads 12K

A lively crowd celebrating with flares, illuminating the night with vibrant fire and smoke.
Credit: pexels.com, A lively crowd celebrating with flares, illuminating the night with vibrant fire and smoke.

Chemring Group PLC is a leading global provider of technology-based solutions. The company was founded in 1984.

Chemring Group's business is organized into two main segments: Chemring Defence and Chemring Electronics. Chemring Defence focuses on providing protection and survivability solutions for military forces, while Chemring Electronics specializes in electronic countermeasures and other electronic systems.

Chemring Group operates in over 30 countries worldwide.

Operations and Performance

Chemring Group operates in four market sectors, which is a testament to its diversification and expansion efforts.

The corporation owns Chemring Nobel, which it acquired as of 2023.

PLC in Aerospace & Defense

Chemring Group PLC has been a leading player in the aerospace and defense industry since its inception in 1905.

The company provides a wide range of products and services, including countermeasures, sensors, information, and energetic products.

Chemring Group PLC offers a variety of sensors and information products, such as point chemical detectors, JSLSCAD, and I-SCAD.

Close-up of a fighter jet pilot in cockpit, showcasing military aviation technology against clouded backdrop.
Credit: pexels.com, Close-up of a fighter jet pilot in cockpit, showcasing military aviation technology against clouded backdrop.

Their products include the R Visor, 3D radars, and Husky mounted detection system, which are used for various applications.

The company also provides advisory, research, and design and engineering services to support their product offerings.

Chemring Group PLC's countermeasures and energetics products include aerodynamic and countermeasure flares, chaf carts, and initiator systems.

Their energetic products include pressure cartridges, initiators, actuators, retractors, and time delay devices.

Chemring Group PLC's products are used in various defense and aerospace applications, including the joint combined aircrew system and system communication and oxygen systems.

The company's products have been used in various military operations, including the development of advanced performance bangalore torpedoes.

Chemring Group PLC's expertise in energetic products has also led to the development of advanced propellants for ejection systems and rocket motors.

Operations

Chemring Group operates in four market sectors, which is a significant part of its business.

The corporation owns Chemring Nobel, a company it acquired as of 2023, and formerly it was known as Dyno Nobel.

Curious to learn more? Check out: Nobel Biocare

Profit and Income

Credit: youtube.com, Revenue vs. Gross Income/Profit/Earnings vs. Net Income/Profit/Earnings (Bottom Line) in One Minute

The company's profitability and income statement is a crucial aspect of its operations and performance. The profit margin is a notable 8.35%, indicating that the company is able to maintain a significant portion of its revenue as profit.

The return on assets (ROA) is 6.24%, which suggests that the company is efficiently using its assets to generate revenue. This is a respectable figure, indicating that the company is making the most of its resources.

Return on equity (ROE) is an impressive 14.59%, indicating that the company is generating substantial profits from shareholder equity. This is a strong indicator of the company's financial health and stability.

Revenue for the most recent period is £521.3M, which is a significant amount of money. Net income available to common shareholders is £51.3M, which is a substantial portion of the revenue.

Here's a breakdown of the company's profitability metrics:

Diluted earnings per share (EPS) is £0.25, which is a respectable figure indicating the company's ability to generate profits for shareholders.

Valuation and Controversy

Credit: youtube.com, Chemring Energetics UK (CEUK)

Chemring Group's valuation measures paint a picture of a company with a significant market presence. The company's market capitalization is a substantial 2.15 billion pounds, with an enterprise value of 2.28 billion pounds.

The company's price-to-earnings (P/E) ratio is 32.78, while its forward P/E ratio is 26.39. This suggests that investors are expecting the company's earnings to grow in the future.

Here are some key valuation measures for Chemring Group:

  • Market Cap: 2.15B
  • Enterprise Value: 2.28B
  • Trailing P/E: 32.78
  • Forward P/E: 26.39
  • PEG Ratio (5yr expected): 1.63
  • Price/Sales (ttm): 3.22
  • Price/Book (mrq): 4.63
  • Enterprise Value/Revenue: 3.24
  • Enterprise Value/EBITDA: 17.48

Meanwhile, Chemring Group has been embroiled in controversy over the years, including allegations of selling landmines to countries where they are banned. The company has denied these allegations, but it's clear that their business practices have been called into question.

Valuation Measures

The valuation measures are a crucial aspect of understanding a company's worth. Market capitalization, or Market Cap, stands at $2.15 billion.

One way to gauge a company's value is by looking at its Enterprise Value, which is $2.28 billion. This figure takes into account the company's debt and cash on hand.

Credit: youtube.com, How to Value a Company | Best Valuation Methods

The Trailing P/E, or price-to-earnings ratio, is a key metric for investors. It's currently at 32.78, indicating that the company's stock price is relatively high compared to its earnings.

A lower P/E ratio can indicate a more undervalued stock. The Forward P/E is 26.39, suggesting that investors expect the company's earnings to grow in the future.

The PEG Ratio (5yr expected) is 1.63, which is a measure of the company's growth prospects. A PEG Ratio of 1 or less is often considered a good sign.

Here are some key valuation metrics in a concise table:

These metrics provide a snapshot of the company's valuation. The Enterprise Value/EBITDA ratio of 17.48 suggests that the company's stock price is relatively high compared to its earnings before interest, taxes, depreciation, and amortization.

Controversy

Chemring Group has been involved in several controversies over the years. In 2002, a report on the BBC Today programme claimed that a salesman from PW Defence, a Chemring subsidiary, had agreed to sell landmines to an undercover reporter.

A Group of People Holding Placards
Credit: pexels.com, A Group of People Holding Placards

The company was accused of selling anti-personnel weapons, which were outlawed in the UK in 1998. Chemring Group insisted that it had never manufactured such products and had halted sales well in advance of the ban.

Six months after the initial report, Chemring was exonerated of any wrongdoing, but a dispute between the BBC and Chemring continued for two years. The controversy surrounding Chemring's alleged involvement in selling landmines has had lasting consequences.

In 2011, it was revealed that CS gas produced by Chemring had been used against civilian pro-democracy protesters in the 2011 Egyptian revolution. The use of CS gas against protesters has been a recurring issue for Chemring.

In 2014, it was also revealed that tear gas used against demonstrators in the 2014 Hong Kong protests was provided by Chemring. The UK Government ordered an immediate end to such sales to the region in June 2019.

The Serious Fraud Office (SFO) has opened an investigation into corruption and money laundering by Chemring Group, following a report from Chemring's subsidiary, Chemring Technology Solutions (CTSL). The investigation is focused on "the conduct of business by Chemring Group and CTSL".

Frequently Asked Questions

Is Chemring a buy?

Chemring is considered a Strong Buy by analysts, with a consensus rating based on 5 buy ratings and no sell ratings. It has 12.02% upside potential according to the average price target.

Where is the Chemring group located?

Chemring's head office is located just outside of Romsey in Hampshire, near Southampton. It serves as the main base for the company's senior leadership team and key corporate functions.

Abraham Lebsack

Lead Writer

Abraham Lebsack is a seasoned writer with a keen interest in finance and insurance. With a focus on educating readers, he has crafted informative articles on critical illness insurance, providing valuable insights and guidance for those navigating complex financial decisions. Abraham's expertise in the field of critical illness insurance has allowed him to develop comprehensive guides, breaking down intricate topics into accessible and actionable advice.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.